Related Experiment Video
Updated: Nov 12, 2025

A Structured Approach to Extubation in Mechanically Ventilated Rats
Published on: July 18, 2025
Angiotensin 1-7 protects against ventilator-induced diaphragm dysfunction
Toshinori Yoshihara1,2, Rafael Deminice1,3, Hayden W Hyatt1
1Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida, USA.
Angiotensin 1-7 (Ang1-7) protects against ventilator-induced diaphragm dysfunction (VIDD). This peptide therapy reduces oxidative stress and protease activation, preserving diaphragm muscle function during mechanical ventilation.
Area of Science:
- Physiology
- Biochemistry
- Critical Care Medicine
Background:
- Mechanical ventilation (MV) can cause ventilator-induced diaphragm dysfunction (VIDD), characterized by inspiratory muscle weakness.
- VIDD pathogenesis involves oxidative stress and accelerated proteolysis in diaphragm fibers, hindering patient weaning from MV.
- Current strategies to prevent VIDD are lacking, necessitating the development of novel therapeutic approaches.
Purpose of the Study:
- To investigate the protective effects of the nonclassical renin-angiotensin system (RAS) pathway, specifically angiotensin 1-7 (Ang1-7), against VIDD.
- To determine if Ang1-7 can mitigate MV-induced diaphragmatic atrophy and contractile dysfunction.
- To elucidate the mechanisms by which Ang1-7 exerts its protective effects, focusing on oxidative stress and protease activation.
Main Methods:
- Utilized an established animal model of prolonged mechanical ventilation.
- Administered Ang1-7 via infusion to assess its impact on diaphragm function and structure.
- Evaluated diaphragm muscle fibers for contractile properties, atrophy, mitochondrial damage, oxidative stress markers, and protease activation.
Main Results:
- Infusion of Ang1-7 significantly protected the diaphragm against MV-induced contractile dysfunction and fiber atrophy in both fast and slow muscle fibers.
- Ang1-7 treatment shielded diaphragm fibers from MV-induced mitochondrial damage and reduced oxidative stress.
- Ang1-7 administration diminished protease activation within diaphragm fibers, a key factor in VIDD development.
Conclusions:
- Angiotensin 1-7 (Ang1-7) demonstrates significant therapeutic potential in preventing ventilator-induced diaphragm dysfunction (VIDD).
- Ang1-7 protects against diaphragm atrophy and contractile dysfunction by mitigating oxidative stress and protease activation.
- These findings support Ang1-7 as a promising strategy to preserve diaphragm function in patients requiring prolonged mechanical ventilation.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Ventilatory Modes
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
Antihypertensive Drugs: Direct Renin Inhibitors
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...

